#glp-1-drugs

[ follow ]
#chronic-conditions

Ars Live: What else can GLP-1 drugs do? Join us Tuesday for a discussion.

GLP-1 drugs have significant roles beyond diabetes and obesity treatment, engaging multiple body systems and presenting new avenues for chronic condition research.

A New Study Explored the Pros and Cons of Drugs Like Ozempic

GLP-1 drugs like Ozempic and Wegovy show promise in treating various health conditions beyond diabetes, but also carry risks for some chronic issues.

Ars Live: What else can GLP-1 drugs do? Join us Tuesday for a discussion.

GLP-1 drugs have significant roles beyond diabetes and obesity treatment, engaging multiple body systems and presenting new avenues for chronic condition research.

A New Study Explored the Pros and Cons of Drugs Like Ozempic

GLP-1 drugs like Ozempic and Wegovy show promise in treating various health conditions beyond diabetes, but also carry risks for some chronic issues.
morechronic-conditions
#weight-loss

Eli Lilly's weight-loss drug may prevent diabetes - but there's 1 unanswered question

GLP-1 drugs Zepbound and Mounjaro significantly reduce diabetes risk by 94% while aiding substantial weight loss in pre-diabetic adults.

1 in 4 companies say they are considering covering weight-loss drug costs

Employers are cautiously considering covering anti-obesity medications despite significant cost concerns and varying interest based on company size.

10 Surprising Secret Benefits of GLP-1: Weight Loss Drugs

GLP-1 weight loss drugs offer unexpected health benefits beyond weight reduction, including improved blood sugar control, heart protection, brain health, and kidney safeguarding.

Not Everyone Loses Weight on Ozempic

Not all patients experience substantial weight loss with GLP-1 drugs, showcasing the variability in response to anti-obesity medications.

Forget keto - Ozempic might finally kill the low-carb diet trend

Weight loss drugs like Ozempic are surpassing keto in popularity due to the significant weight loss associated with GLP-1 drugs.

What It's Really Like to Take Ozempic

GLP-1 drugs like Ozempic have revolutionized weight management, offering both significant benefits and complex emotional experiences for patients.

Eli Lilly's weight-loss drug may prevent diabetes - but there's 1 unanswered question

GLP-1 drugs Zepbound and Mounjaro significantly reduce diabetes risk by 94% while aiding substantial weight loss in pre-diabetic adults.

1 in 4 companies say they are considering covering weight-loss drug costs

Employers are cautiously considering covering anti-obesity medications despite significant cost concerns and varying interest based on company size.

10 Surprising Secret Benefits of GLP-1: Weight Loss Drugs

GLP-1 weight loss drugs offer unexpected health benefits beyond weight reduction, including improved blood sugar control, heart protection, brain health, and kidney safeguarding.

Not Everyone Loses Weight on Ozempic

Not all patients experience substantial weight loss with GLP-1 drugs, showcasing the variability in response to anti-obesity medications.

Forget keto - Ozempic might finally kill the low-carb diet trend

Weight loss drugs like Ozempic are surpassing keto in popularity due to the significant weight loss associated with GLP-1 drugs.

What It's Really Like to Take Ozempic

GLP-1 drugs like Ozempic have revolutionized weight management, offering both significant benefits and complex emotional experiences for patients.
moreweight-loss
#weight-loss-drugs

Cheaper Versions of Popular New Weight-Loss Drugs Are Being Developed

Chinese and Indian pharmaceutical companies are developing cheaper weight-loss drug versions to reach more people globally.

Maker of weight-loss drugs to ask Trump to pause price negotiations: Report

Biden administration proposed allowing Medicare to cover anti-obesity medications to improve long-term health and reduce future costs.
CBO predicts Medicare's anti-obesity drug coverage would lead to significant net costs for taxpayers.

Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in

Smaller competitors are preparing to enter the weight-loss drug market dominated by Eli Lilly and Novo Nordisk.

Cheaper Versions of Popular New Weight-Loss Drugs Are Being Developed

Chinese and Indian pharmaceutical companies are developing cheaper weight-loss drug versions to reach more people globally.

Maker of weight-loss drugs to ask Trump to pause price negotiations: Report

Biden administration proposed allowing Medicare to cover anti-obesity medications to improve long-term health and reduce future costs.
CBO predicts Medicare's anti-obesity drug coverage would lead to significant net costs for taxpayers.

Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in

Smaller competitors are preparing to enter the weight-loss drug market dominated by Eli Lilly and Novo Nordisk.
moreweight-loss-drugs

The weight loss drug revolution is shrinking America's waistline

GLP-1 drugs are potentially reversing America's obesity crisis with projected usage rising to 18 million by 2029.
#obesity-treatment

Why do obesity drugs seem to treat so many other ailments?

GLP-1 drugs may reduce cravings for alcohol and other addictions while also addressing obesity and other health conditions.

Scientists Who Pioneered GLP-1 Drugs Honored With Award

Lasker Awards highlight significant contributions to medical research, recognizing advances in obesity treatment through GLP-1-based drugs.

Opinion | Pfizer Stopped Us From Getting Ozempic Decades Ago

GLP-1 drugs have the potential to significantly impact obesity and multiple chronic diseases, shaping healthcare for years to come.

Why do obesity drugs seem to treat so many other ailments?

GLP-1 drugs may reduce cravings for alcohol and other addictions while also addressing obesity and other health conditions.

Scientists Who Pioneered GLP-1 Drugs Honored With Award

Lasker Awards highlight significant contributions to medical research, recognizing advances in obesity treatment through GLP-1-based drugs.

Opinion | Pfizer Stopped Us From Getting Ozempic Decades Ago

GLP-1 drugs have the potential to significantly impact obesity and multiple chronic diseases, shaping healthcare for years to come.
moreobesity-treatment

Why Is There So Much Off-Brand Oral Ozempic for Sale Online?

Oral compounded versions of GLP-1 drugs are gaining popularity despite lacking evidence of efficacy.
The rise of these medications follows injectable versions facing shortages.
Compounded drugs are often cheaper and more convenient, appealing to patients afraid of needles.

Weight loss care is leading IPO-hopeful Omada Health's latest growth surge as Ozempic boom continues

Omada Health's weight loss program is driving its growth and public market ambitions, with a notable shift towards GLP-1 care.

More Than 900 Patients Say Ozempic and Similar Drugs Unexpectedly Injured Them

Over 900 individuals are suing drugmakers, claiming GLP-1 drugs like Ozempic caused severe gastrointestinal injuries, even after stopping usage.

2 Weight Loss Drug Stocks Worth Stashing Away for Years

High-growth sectors, including GLP-1 drugs and AI, face potential corrections despite long-term growth expectations.
Top stocks may be overpriced, leading to painful corrections as market recalibrates valuations.

Weight-loss drug boom sparks battle over pharmacy copycats

The surge in compounded GLP-1 drugs addresses availability but leads to regulatory issues and legal battles.
Compounding offers personalized medication options, even amidst drug shortages.

Researchers Say There's Something Fishy With All These Studies Showing Huge Health Benefits From Ozempic-Like Drugs

The recent commentary highlights conflicts of interest surrounding GLP-1 weight loss drugs and the need for unbiased research funding.

Workplace insurance could soon be stripped down

Rising demand for GLP-1 drugs is driving up workplace insurance costs, leading to predictions of reduced employee benefits.

Ozempic and Wegovy should be covered by Medicare as weight loss treatments: KFF poll

GLP-1 drugs used for diabetes and heart disease gaining popularity as weight loss treatments.
KFF survey shows limited usage of GLP-1 drugs for weight loss, with interest in Medicare coverage for weight loss drugs.
#hims--hers-health

Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.

Hims & Hers Health offers GLP-1 weight loss drugs at a fraction of the cost of brand-name competitors, leading to a significant increase in shares.

Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortages

Hims & Hers Health announced the addition of GLP-1 injectable drugs to its offerings at significantly reduced prices, leading to a surge in stock prices.

Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.

Hims & Hers Health offers GLP-1 weight loss drugs at a fraction of the cost of brand-name competitors, leading to a significant increase in shares.

Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortages

Hims & Hers Health announced the addition of GLP-1 injectable drugs to its offerings at significantly reduced prices, leading to a surge in stock prices.
morehims--hers-health

10 Facts About GLP-1 Weight Loss Medications Your Doctor Might Not Mention

Needle phobia can impact GLP-1 therapy, while managing feeling of fullness is crucial for successful treatment.
from www.scientificamerican.com
6 months ago

What's the Secret behind Ozempic's Sweeping Health Benefits?

GLP-1 drugs like Ozempic have broader medical applications beyond diabetes and weight loss, showing promise in treating kidney, cardiovascular, liver diseases, and neurological disorders.

Taking Ozempic or other weight-loss meds? Watch your diet to avoid exchanging one problem for another'

GLP-1 drugs like Wegovy are helping with weight loss by changing eating habits and increasing satiation.

Daily briefing: How obesity drugs like Ozempic create a full feeling

Identified brain area in hypothalamus responsible for fullness in GLP-1 drug users
[ Load more ]